Literature DB >> 30258163

Searching for the roots of brain cancer.

Neil Savage.   

Abstract

Entities:  

Keywords:  Brain; Cancer; Epidemiology; Neuroscience

Mesh：

Substances：

Year:  2018        PMID： 30258163     DOI： 10.1038/d41586-018-06709-2

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.

Authors:  E Susan Amirian; Renke Zhou; Margaret R Wrensch; Sara H Olson; Michael E Scheurer; Dora Il'yasova; Daniel Lachance; Georgina N Armstrong; Lucie S McCoy; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Jonine L Bernstein; Ryan T Merrell; Faith G Davis; Rose Lai; Sanjay Shete; Christopher I Amos; Beatrice S Melin; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

2.  Familiality in brain tumors.

Authors:  Deborah T Blumenthal; Lisa A Cannon-Albright
Journal:  Neurology       Date:  2008-09-23       Impact factor: 9.910

3.  A nested case-control study of 277 prediagnostic serum cytokines and glioma.

Authors:  Judith Schwartzbaum; Min Wang; Elisabeth Root; Maciej Pietrzak; Grzegorz A Rempala; Ruo-Pan Huang; Tom Borge Johannesen; Tom K Grimsrud
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

4.  Associations between prediagnostic blood glucose levels, diabetes, and glioma.

Authors:  Judith Schwartzbaum; Michael Edlinger; Victoria Zigmont; Pär Stattin; Grzegorz A Rempala; Gabriele Nagel; Niklas Hammar; Hanno Ulmer; Bernhard Föger; Göran Walldius; Jonas Manjer; Håkan Malmström; Maria Feychting
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

5.  Association between prediagnostic IgE levels and risk of glioma.

Authors:  Judith Schwartzbaum; Bo Ding; Tom Borge Johannesen; Liv T N Osnes; Linda Karavodin; Anders Ahlbom; Maria Feychting; Tom K Grimsrud
Journal:  J Natl Cancer Inst       Date:  2012-08-01       Impact factor: 13.506

6.  Germline mutations in shelterin complex genes are associated with familial glioma.

Authors:  Matthew N Bainbridge; Georgina N Armstrong; M Monica Gramatges; Alison A Bertuch; Shalini N Jhangiani; Harsha Doddapaneni; Lora Lewis; Joseph Tombrello; Spyros Tsavachidis; Yanhong Liu; Ali Jalali; Sharon E Plon; Ching C Lau; Donald W Parsons; Elizabeth B Claus; Jill Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Daniel Lachance; Sara H Olson; Jonine L Bernstein; Ryan T Merrell; Margaret R Wrensch; Kyle M Walsh; Faith G Davis; Rose Lai; Sanjay Shete; Kenneth Aldape; Christopher I Amos; Patricia A Thompson; Donna M Muzny; Richard A Gibbs; Beatrice S Melin; Melissa L Bondy
Journal:  J Natl Cancer Inst       Date:  2014-12-07       Impact factor: 11.816

7.  History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC).

Authors:  E Susan Amirian; Michael E Scheurer; Renke Zhou; Margaret R Wrensch; Georgina N Armstrong; Daniel Lachance; Sara H Olson; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Robert B Jenkins; Jonine L Bernstein; Ryan T Merrell; Faith G Davis; Rose Lai; Sanjay Shete; Christopher I Amos; Beatrice S Melin; Melissa L Bondy
Journal:  Cancer Med       Date:  2016-03-13       Impact factor: 4.452
  7 in total
  8 in total

1.  CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K/AKT/mTOR pathways in glioma.

Authors:  Tong Cao; Yue Cui; Yingying Wang; Linhui Wu; Ke Yu; Kai Chen; Jun Xia; Yuyun Li; Zhiwei Peter Wang; Jia Ma
Journal:  Apoptosis       Date:  2022-08-29       Impact factor: 5.561

Review 2.  Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments.

Authors:  Alex J McCraw; Jitesh Chauhan; Heather J Bax; Chara Stavraka; Gabriel Osborn; Melanie Grandits; Jacobo López-Abente; Debra H Josephs; James Spicer; Gerd K Wagner; Sophia N Karagiannis; Alicia Chenoweth; Silvia Crescioli
Journal:  Cancers (Basel)       Date:  2021-09-04       Impact factor: 6.575

3.  Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma.

Authors:  Yulian Zhang; Chuanpeng Zhang; Yanbo Yang; Guohui Wang; Zai Wang; Jiang Liu; Li Zhang; Yanbing Yu
Journal:  Front Cell Dev Biol       Date:  2022-04-25

4.  Exosomal microRNA-210 is a potentially non-invasive biomarker for the diagnosis and prognosis of glioma.

Authors:  Fengming Lan; Xiao Yue; Tingyi Xia
Journal:  Oncol Lett       Date:  2020-01-07       Impact factor: 2.967

5.  Association Between Genetic Polymorphisms In TYMS And Glioma Risk In Chinese Patients: A Case-Control Study.

Authors:  Li Yao; Linghui Zhou; Yujiao Deng; Yi Zheng; Pengtao Yang; Meng Wang; Shanshan Dong; Qian Hao; Peng Xu; Na Li; Ying Wu; Zhen Zhai; Lijuan Lyu; Zhijun Dai
Journal:  Onco Targets Ther       Date:  2019-10-07       Impact factor: 4.147

6.  Long Non-coding RNA LINC00320 Inhibits Tumorigenicity of Glioma Cells and Angiogenesis Through Downregulation of NFKB1-Mediated AQP9.

Authors:  Lisha Chang; Zhe Bian; Xin Xiong; Jian Liu; Dali Wang; Fuling Zhou; Jiang Zhang; Yunhe Zhang
Journal:  Front Cell Neurosci       Date:  2020-12-22       Impact factor: 5.505

7.  Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma.

Authors:  Rongrong Liu; Weidong Liang; Qian Hua; Longqiu Wu; Xiangcai Wang; Qiang Li; Fangjun Zhong; Bin Li; Zhengang Qiu
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

8.  A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.

Authors:  Guohui Wang; Huandi Zhou; Lei Tian; Tianfang Yan; Xuetao Han; Pengyu Chen; Haonan Li; Wenyan Wang; Zhiqing Xiao; Liubing Hou; Xiaoying Xue
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.